Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alleviation by NIAGEN of Persistent Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors

NCT04112641 is registered in ClinicalTrials.gov with Donna Hammond, PhD as lead sponsor.

NCT NCT04112641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04112641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alleviation by NIAGEN of Persistent Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors
Lead sponsor
Donna Hammond, PhD
Phase
Phase 2
Overall status
Active, not recruiting
Start date
February 19, 2020
Completion date
December 1, 2027
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced peripheral neuropathy